Welcome to our spotlight on immunotherapy!

Quick access to all the content in the latest RegMedNet spotlight, including expert editorials, peer-reviewing journal content and more.

Go to the profile of RegMedNet
Sep 01, 2018

Visit the spotlight

Immunotherapy is a rapidly developing therapeutic approach that involves harnessing a patient’s immune system to fight disease, often cancer or immune disorders such as allergies. In recent years, the first immunotherapies for cancer have been trialled, approved and administered to patients; some offering amazing results.

Cellular immunotherapies, such as CAR-T or T-cell receptor therapies, have the potential to fight cancer and other disorders very effectively and provide a long lasting regression from illness. However, they are currently very expensive to produce and administer, making the final cost of the treatment very high. We also don’t fully understand why they work in some patients and not others. Finally, even in the patients they are effective in, there is the risk of very serious side effects.

The spotlight will aim to review advancements and current obstacles in the manufacture and administration of immunotherapies with a focus on consistency, safety and efficacy. We will look into potential indications of immunotherapies, what to consider in their development and how these therapies are going to evolve and change healthcare in the coming years.

Visit the spotlight - new posts weekly!


Editorials and interviews




Journal articles


Go to the profile of RegMedNet


eCommunity, Future Science Group

RegMedNet is a networking site where users can share their knowledge and insights. This profile will share some content and updates from the RegMedNet team, including webinars, news and journal articles.

No comments yet.